Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (221-230 of 509) with videos related to

Pageof 51
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and GlycemiaMikkel B Christensen, Asger Lund, Salvatore Calanna, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2021
Expression of Cholecystokinin and its Receptors in the Intestinal Tract of Type 2 Diabetes Patients and Healthy ControlsHannah Gilliam-Vigh, Tina Jorsal, Jens F Rehfeld, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitusKristine J Hare, Filip K Knop, Meena Asmar, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 4, 2020
Reduced erythrocyte lifespan measured by chromium-51 in patients with type 2 diabetes undergoing long-term hemodialysisTobias Bomholt, Peter Oturai, Marianne Rix, et al.
Diabetes|March 29, 2014
Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3Signe H Østoft, Jonatan I Bagger, Torben Hansen, et al.
Endocrine Connections|June 6, 2024
Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover studyNiels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, et al.
Journal of Advanced Nursing|November 1, 2019
Experience of family function, family involvement, and self-management in adult patients with type 2 diabetes: A thematic analysisBirgitte B Bennich, Lene Munch, Dorthe Overgaard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2014
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients--a randomized placebo-controlled trialA Faurschou, M Gyldenløve, U Rohde, et al.
World Journal of Hepatology|March 2, 2019
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effectsTea L Laursen, Christoffer A Hagemann, Chunshan Wei, et al.
International Journal of Bipolar Disorders|April 3, 2019
Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relativesKlara Coello, Maj Vinberg, Filip K Knop, et al.
Pageof 51

Showing results (221-230 of 509) with videos related to

Sort By:
Pageof 51
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and GlycemiaMikkel B Christensen, Asger Lund, Salvatore Calanna, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2021
Expression of Cholecystokinin and its Receptors in the Intestinal Tract of Type 2 Diabetes Patients and Healthy ControlsHannah Gilliam-Vigh, Tina Jorsal, Jens F Rehfeld, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitusKristine J Hare, Filip K Knop, Meena Asmar, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 4, 2020
Reduced erythrocyte lifespan measured by chromium-51 in patients with type 2 diabetes undergoing long-term hemodialysisTobias Bomholt, Peter Oturai, Marianne Rix, et al.
Diabetes|March 29, 2014
Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3Signe H Østoft, Jonatan I Bagger, Torben Hansen, et al.
Endocrine Connections|June 6, 2024
Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover studyNiels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, et al.
Journal of Advanced Nursing|November 1, 2019
Experience of family function, family involvement, and self-management in adult patients with type 2 diabetes: A thematic analysisBirgitte B Bennich, Lene Munch, Dorthe Overgaard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2014
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients--a randomized placebo-controlled trialA Faurschou, M Gyldenløve, U Rohde, et al.
World Journal of Hepatology|March 2, 2019
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effectsTea L Laursen, Christoffer A Hagemann, Chunshan Wei, et al.
International Journal of Bipolar Disorders|April 3, 2019
Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relativesKlara Coello, Maj Vinberg, Filip K Knop, et al.
Pageof 51